DGCI

DGCI sends Notice to Glenmark Pharmaceuticals over antiviral drug FabiFlu for COVID-19 Patients

Sukant Sharma 20 July 2020
DGCI sends Notice to Glenmark Pharmaceuticals over antiviral drug FabiFlu for COVID-19 Patients

Glenmark Pharmaceuticals has received a notice from the Drugs Controller General of India (DGCI) regarding pricing of antiviral drug FabiFlu that has been effective is recovery of some COVID-19 pat

.

Esteemed India:: India Media Hub:: Indian Rummy:: Latest News:: Mid-Cap Stocks:: Sports Bazaar